Emotion Regulation Individual Therapy for Adolescents With NSSI

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy for Adolescents (ERITA) who self-harm.

n/a

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06038942` - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress	N/A
Completed	`NCT05608304` - Formal Versus Informal Mindfulness Among University Students With and Without Recent Nonsuicidal Self-injury	N/A
Completed	`NCT03353961` - Internet Delivered ERITA for Nonsuicidal Self-Injury	N/A
Completed	`NCT03548402` - Acceptance and Commitment Therapy for Nonsuicidal Self-injury	N/A
Withdrawn	`NCT03550521` - Interrupting Self-Harm Study	N/A
Completed	`NCT05935345` - Addressing Nonsuicidal Self-injury in Schools	N/A
Completed	`NCT03655470` - Safety Planning in Juvenile Justice for Suicidal Youth	N/A
Completed	`NCT02697019` - Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study	N/A